1. The Guardian Connect system uses predictive analytics and artificial intelligence technology from IBM Watson Health to analyze glucose levels.
2. Adcetris is the first new frontline treatment for advanced Hodgkin lymphoma in 40 years.
3. Lucentis is available as a 0.3 milligram prefilled syringe to treat diabetic macular edema and diabetic retinopathy.
4. Hizentra is the first subcutaneous immunoglobulin approved to treat chronic inflammatory demyelinating polyneuropathy, a rare autoimmune disorder that affects the peripheral nerves.
More articles on supply chain:
US grants Amazon patent for drones that react to human gestures
California issues cease-and-desist order to subsidiary of AmerisourceBergen: 6 things to know
FDA approves first frontline treatment for advanced Hodgkin lymphoma in 40 years
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
